OakChart

Atricure Inc

ATRCHealthcare·Medical Instruments & Supplies·USA·Mid·NASD·Nov 12 • 3:59 PM ET

55.98-1.55 (-2.69%)
2026-11-13 13:07 CET
Market cap
$2.85B
Revenue, TTM
589.80 USD m
Net income, TTM
14.88 USD m
Free cash flow, TTM
52.94 USD m
EPS diluted, TTM
0.30
184.39
Compare

Price

ATRC against its 20, 50 and 200-day averages
Terms2050200Beat
Patternshover a marker to name it
RS 100Sales 159Price15916030.0040.0050.0060.004.3M8.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ATRCclose 55.9820-day 59.3150-day 57.39200-day 38.9955.9852w high 66.0252w low 25.3652-week range, not 6 months

15.2% under the 52-week high of 66.02 on 4 Nov 2026. 52-week low 25.36 on 2 Jun 2026. Last 15 sessions, 20.6% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 100
CANSLIM 5 of 6 — fails: 52-Week High/Low: 0-10% below High
VCP 4 of 6 — fails: 52-Week High/Low: 0-10% below High; Average True Range: Under 2
Minervini 3 of 4 — fails: 52-Week High/Low: 0-10% below High
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 3 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 52-Week High/Low: 0-10% below High
Breakout 1 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50
Growth 3 of 4 — fails: Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: P/E: Under 15; P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years; P/E: Under 25 — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%)
Small Cap 4 of 4
Accumulation 4 of 4
Relative Strength 2 of 3 — fails: Performance: Year +100%

Profile

ATRC
52-week range, 75% of the way up
25.3666.02

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

IndexRUT
Employees1350
IPOAug 05, 2005
Beta1.22
ATR, 14d2.75
Rel volume0.00
Short float9.99%
Insider own3.92%
Inst own106.13%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$2.85B
Enterprise Value2.76B
Income14.88M
Sales589.80M
Book / share10.47
Cash / share3.67
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1350
IPOAug 05, 2005

Ratios

Price / earnings184.39
Forward price / earnings118.83
Price / earnings / growth-
Price / sales4.83
Price / book5.35
Price / cash15.24
Price / free cash flow53.85
Value / cash profit70.42
Value / sales4.68
Quick Ratio3.29
Current Ratio4.33
Debt / equity0.18
Long-term debt / equity0.17
Options and shortYes / Yes

Earnings

Earnings / share0.30
Earnings next year0.47
Earnings next quarter-0.01
Earnings this year196.35%
Earnings next year103.72%
Earnings growth, 5 years-
Past earnings growth38.20% 26.83%
Past sales growth17.40% 20.95%
Earnings vs last year150.33%
Sales vs last year13.79%
Earnings vs last quarter1557.14%
Sales vs last quarter15.03%
EarningsNov 03 AMC
Surprise244.93% 2.25%

Ownership

Insiders own3.92%
Insider trades-4.48%
Institutions own106.13%
Institution trades13.01%
Return on assets2.20%
Return on equity2.95%
Return on capital2.38%
Gross Margin76.24%
Operating margin3.06%
Profit Margin2.52%
20-day average-5.61%
50-day average-2.46%
200-day average43.57%

Technical

Shares out50.91M
Shares floating48.93M
Short / float9.99%
Short ratio4.68
Short interest4.89M
52-week high66.02 -15.2%
52-week low25.36 +120.7%
Volatility4.40% 4.51%
Average range2.75
Strength index44.25
Market sensitivity1.22
Relative volume0.00
Avg Volume1.04M
Volume0

Performance

Perf Week-8.65%
Perf Month-2.30%
Perf Quarter26.37%
Perf Half Y98.86%
Perf YTD41.51%
Perf Year69.33%
Perf 3Y59.62%
Perf 5Y-27.50%
Perf 10Y180.60%
Recommendation1.67
Target Price66.75
Prev Close55.98
Price55.98
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Feb 18, 2026DowngradeOppenheimerOutperform → Perform
Feb 11, 2026DowngradeJP MorganOverweight → Neutral$36-35.7%
Dec 17, 2024ResumedJP MorganOverweight$40-28.5%
Apr 23, 2024UpgradeOppenheimerPerform → Outperform$32-42.8%
Oct 23, 2023InitiatedJMP SecuritiesMkt Outperform$60+7.2%
Sep 29, 2023InitiatedUBSBuy$560.0%
Aug 05, 2021DowngradeOppenheimerOutperform → Perform
Dec 18, 2020ReiteratedNeedhamBuy$53 → $63+12.5%
Nov 06, 2020ReiteratedNeedhamBuy$63 → $53-5.3%
Apr 07, 2020InitiatedOppenheimerOutperform$45-19.6%

Peers

Mkt cap
TickerCompanyMkt cap
BSXBoston Scientific Corp64.24B
MDTMedtronic Plc129.18B
ABTAbbott Laboratories186.05B
AORTArtivion Inc942.67M
TFXTeleflex Incorporated6.08B
STXSStereotaxis Inc85.17M
ANGOAngiodynamic Inc504.02M
LIVNLivaNova PLC4.97B
JNJJohnson & Johnson682.83B
EWEdwards Lifesciences Corp60.83B

Insider trading

latest 14 of 42
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
JOHNSON B KRISTINEDirectorNov 06 '26Sale58.482,452143,39353,502Nov 10 04:02 PM
B KRISTINE JOHNSON DECLARATIONDirectorNov 06 '26Proposed Sale58.482,452143,397Nov 06 04:04 PM
Privitera SalvatoreChief Technical OfficerNov 04 '26Sale65.008,404546,260134,341Nov 05 04:17 PM
SALVATORE PRIVITERAOfficerNov 04 '26Proposed Sale65.008,404546,260Nov 04 04:05 PM
Privitera SalvatoreChief Technical OfficerSep 23 '26Sale60.004,519271,140142,745Sep 24 05:00 PM
SALVATORE PRIVITERAOfficerSep 23 '26Proposed Sale60.004,519271,140Sep 23 04:03 PM
GROVES REGINA EDirectorSep 11 '26Sale54.225,313288,07134,546Sep 14 05:44 PM
GROVES REGINA EDirectorSep 10 '26Proposed Sale53.665,313285,096Sep 11 10:59 AM
Privitera SalvatoreChief Technical OfficerSep 08 '26Sale55.003,657201,135147,264Sep 10 09:18 AM
SALVATORE PRIVITERAOfficerSep 08 '26Proposed Sale55.003,657201,135Sep 08 04:17 PM
Privitera SalvatoreChief Technical OfficerSep 02 '26Sale52.507,763407,558150,921Sep 04 07:39 AM
SALVATORE PRIVITERAOfficerSep 02 '26Proposed Sale52.507,763407,558Sep 02 05:15 PM
Dahlquist Karl S.Chief Legal OfficerAug 24 '26Sale48.899,370458,09987,319Aug 26 06:50 AM
KARL DAHLQUISTOfficerAug 24 '26Proposed Sale48.899,370458,091Aug 24 04:11 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 107.13B
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VBVanguard Morningstar Small-Cap ETFAUM: 80.23B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.68B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.90B
VXFVanguard Extended Market Index ETFAUM: 30.79B
IWOiShares Russell 2000 Growth ETFAUM: 14.25B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.19B
IJTiShares S&P Small-Cap 600 Growth ETFAUM: 7.52B

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS 0.080 beat -0.055, from -0.010 a year earlier. Sales 154.45 beat 151.05, from 134.27 a year earlier
EPS
0.1800-0.3302024Q4 EPS -0.330 against -0.20224Q42025Q1 EPS -0.140 against -0.22525Q12025Q2 EPS -0.130 against -0.16725Q22025Q3 EPS -0.010 against -0.11225Q32025Q4 EPS 0.040 against -0.08725Q42026Q1 EPS 0.000 against -0.05926Q12026Q2 EPS 0.180 against -0.00226Q22026Q3 EPS 0.080 against -0.05526Q3
Sales, USD millions
154.4502024Q4 sales 124.28 against 121.2524Q42025Q1 sales 123.62 against 122.925Q12025Q2 sales 136.14 against 130.1825Q22025Q3 sales 134.27 against 131.2625Q32025Q4 sales 140.5 against 139.7125Q42026Q1 sales 141.25 against 139.7526Q12026Q2 sales 153.6 against 151.826Q22026Q3 sales 154.45 against 151.0526Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-03 16:300.080-0.0550.080154.45151.05EPS -244.9% · sales +2.2%vs 2025Q3, year-ago quarter · EPS -900.0% · sales +15.0%7 EPS · 8 salesOpen -3.89% vs SPY +1.15%. Close +8.48% vs SPY +1.65%
2026Q2ended 2026-06-302026-07-23 16:300.180-0.0020.183153.6151.8EPS -10688.2% · sales +1.2%vs 2025Q2, year-ago quarter · EPS -238.5% · sales +12.8%8 EPS · 9 salesOpen +2.09% vs SPY +0.04%. Close +6.18% vs SPY +0.10%
2026Q1ended 2026-03-312026-05-05 16:300.000-0.0590.002141.25139.75EPS -100.0% · sales +1.1%vs 2025Q1, year-ago quarter · EPS -100.0% · sales +14.3%8 EPS · 9 salesOpen -4.22% vs SPY +0.61%. Close -4.70% vs SPY +1.39%
2025Q4ended 2025-12-312026-02-17 16:300.040-0.0870.037140.5139.71EPS -146.1% · sales +0.6%vs 2024Q4, year-ago quarter · EPS -112.1% · sales +13.1%8 EPS · 9 salesOpen +0.09% vs SPY +0.17%. Close -2.15% vs SPY +0.50%
2025Q3ended 2025-09-302025-10-29 16:30-0.010-0.112-0.006134.27131.26EPS -91.1% · sales +2.3%vs 2024Q3, year-ago quarter · EPS -94.1% · sales +15.8%8 EPS · 9 salesOpen +4.01% vs SPY -0.51%. Close -3.81% vs SPY -1.10%
2025Q2ended 2025-06-302025-07-29 16:30-0.130-0.167-0.130136.14130.18EPS -22.2% · sales +4.6%vs 2024Q2, year-ago quarter · EPS -23.5% · sales +17.1%8 EPS · 9 salesOpen +18.82% vs SPY +0.10%. Close +10.72% vs SPY -0.13%
2025Q1ended 2025-03-312025-04-29 16:30-0.140-0.225-0.142123.62122.9EPS -37.8% · sales +0.6%vs 2024Q1, year-ago quarter · EPS -50.0% · sales +13.6%9Open -10.01% vs SPY -1.22%. Close -13.68% vs SPY +0.04%
2024Q4ended 2024-12-312025-02-12 16:30-0.330-0.202-0.330124.28121.25EPS +63.1% · sales +2.5%vs 2023Q4, year-ago quarter · EPS +57.1% · sales +16.6%9Open -0.85% vs SPY +0.19%. Close -6.54% vs SPY +1.06%
2024Q3ended 2024-09-302024-10-29 16:30-0.170-0.195-0.167115.91112.23EPS -12.8% · sales +3.3%vs 2023Q3, year-ago quarter · EPS -15.0% · sales +17.9%9Open +16.89% vs SPY -0.08%. Close +18.35% vs SPY -0.30%
2024Q2ended 2024-06-302024-07-30 16:30-0.170-0.168-0.171116.27116.24EPS +1.1% · sales +0.0%vs 2023Q2, year-ago quarter · EPS +54.5% · sales +15.2%8 EPS · 9 salesOpen 0.00% vs SPY +1.29%. Close -1.95% vs SPY +1.63%
2024Q1ended 2024-03-312024-05-01 16:30-0.280-0.229-0.284108.85106.86EPS +22.1% · sales +1.9%vs 2023Q1, year-ago quarter · EPS +100.0% · sales +16.4%8 EPS · 9 salesOpen -8.36% vs SPY +0.76%. Close -10.26% vs SPY +0.94%
2023Q4ended 2023-12-312024-02-15 16:30-0.210-0.225-0.211106.54103.68EPS -6.6% · sales +2.8%vs 2022Q4, year-ago quarter · EPS +133.3% · sales +21.0%9Open -0.18% vs SPY -0.06%. Close -4.36% vs SPY -0.50%
2023Q3ended 2023-09-302023-11-01 16:30-0.200-0.305-0.19598.2996.65EPS -34.3% · sales +1.7%vs 2022Q3, year-ago quarter · EPS -25.9% · sales +18.1%9-
2023Q2ended 2023-06-302023-07-25 16:30-0.110-0.296-0.111100.9297.55EPS -62.9% · sales +3.5%vs 2022Q2, year-ago quarter · EPS -65.6% · sales +19.4%7-
2023Q1ended 2023-03-312023-05-02 16:30-0.140-0.310-0.14193.4988.48EPS -54.9% · sales +5.7%vs 2022Q1, year-ago quarter · EPS -57.6% · sales +25.4%7-
2022Q4ended 2022-12-312023-02-21 16:30-0.090-0.176-0.09188.0387.78EPS -48.9% · sales +0.3%vs 2021Q4, year-ago quarter · EPS -70.0% · sales +20.2%7-

Annual earnings

2025FY EPS -0.240 beat -0.364, from -0.950 a year earlier. Sales 534.53 beat 533.84, from 465.31 a year earlier
EPS
1.0900-1.1402018FY EPS -0.620 against -0.70520182019FY EPS -0.940 against -0.94920192020FY EPS -1.140 against -0.99420202021FY EPS 1.090 against 0.83020212022FY EPS -1.020 against -1.10320222023FY EPS -0.660 against -0.73320232024FY EPS -0.950 against -0.81620242025FY EPS -0.240 against -0.3642025
Sales, USD millions
534.5302018FY sales 201.63 against 200.3820182019FY sales 230.81 against 229.5120192020FY sales 206.53 against 206.9120202021FY sales 274.33 against 273.6920212022FY sales 330.38 against 330.1420222023FY sales 399.25 against 396.4420232024FY sales 465.31 against 462.2720242025FY sales 534.53 against 533.842025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-1.040--982.153.83
2029FYestimate-1.095--855.9651.12
2028FYestimate-0.709--768.2179.00
2027FYestimate-0.471--682.18118.83
2026FYestimate-0.231--608.45242.02
2025FY-0.240-0.364-0.240534.53533.84-
2024FY-0.950-0.816-0.952465.31462.27-
2023FY-0.660-0.733-0.657399.25396.44-
2022FY-1.020-1.103-1.016330.38330.14-
2021FY1.0900.8301.090274.33273.6963.79
2020FY-1.140-0.994-1.143206.53206.91-
2019FY-0.940-0.949-0.936230.81229.51-
2018FY-0.620-0.705-0.620201.63200.38-
2017FY-0.830-0.938-0.830174.72174.23-
2016FY-1.050-1.082-1.050155.11155.74-
2015FY-0.970-0.959-0.970129.76129.76-
2014FY-0.610-0.702-0.610107.45106.41-
2013FY-0.560-0.436-0.56081.8981.28-
2012FY-0.365-0.418-0.47070.2570.32-
2011FY-0.350-0.290-0.35064.4064.81-
2010FY-0.250-0.333-0.25059.0158.06-

Quarterly results

2026Q3 revenue 154.45, from 134.27 a year earlier. Operating margin 2.8%, from 0.2% a year earlier
Revenue, USD millions
154.4502024Q4 revenue 124.2824Q42025Q1 revenue 123.6225Q12025Q2 revenue 136.1425Q22025Q3 revenue 134.2725Q32025Q4 revenue 140.525Q42026Q1 revenue 141.2526Q12026Q2 revenue 153.626Q22026Q3 revenue 154.4526Q3
Operating margin
6.30-4.82024Q4 operating margin -2.0%24Q42025Q1 operating margin -4.8%25Q12025Q2 operating margin -0.9%25Q22025Q3 operating margin 0.2%25Q32025Q4 operating margin 2.5%25Q42026Q1 operating margin 0.4%26Q12026Q2 operating margin 6.3%26Q22026Q3 operating margin 2.8%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 0.23 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-040.23+114.0%
2026Q4Eper share2026-11-04-0.01-291.7%
2026FYRper share2026-11-040.23+114.0%
2026Q4Rper share2026-11-04-0.01-291.7%
2026FYS-2026-11-04608.45+0.4%
2026Q4S-2026-11-04159.44-0.5%
2026Q3Eper share2026-11-01-0.06+13.8%
2026Q3Rper share2026-11-01-0.06+13.8%
2026Q3S-2026-11-01151.05+0.0%
2026Q2Eper share2026-07-200.000.0%
2026Q2Rper share2026-07-200.000.0%
2026Q2S-2026-07-20151.80.0%
2026Q1Eper share2026-05-04-0.060.0%
2026Q1Rper share2026-05-04-0.060.0%
2026Q1S-2026-05-04139.750.0%
2025FYS-2026-02-13533.840.0%
2025Q4S-2026-02-13139.710.0%
2025FYEper share2026-02-11-0.36-1.0%
2025Q4Eper share2026-02-11-0.09-4.1%
2025FYRper share2026-02-11-0.36-1.0%
2025Q4Rper share2026-02-11-0.09-4.1%
2025Q3Eper share2025-10-25-0.110.0%
2025Q3Rper share2025-10-25-0.110.0%
2025Q3S-2025-10-14131.26+0.0%
2025Q2Eper share2025-07-14-0.17+3.9%
2025Q2Rper share2025-07-14-0.17+3.9%
2025Q2S-2025-07-14130.18+0.0%
2025Q1Eper share2025-04-29-0.23-0.1%
2025Q1Rper share2025-04-29-0.23-0.1%
2025Q1S-2025-04-29122.90.0%
2024FYEper share2025-02-10-0.82+0.1%
2024Q4Eper share2025-02-10-0.200.0%
2024FYRper share2025-02-10-0.82+0.1%
2024Q4Rper share2025-02-10-0.200.0%
2024FYS-2025-02-10462.27+0.1%
2024Q4S-2025-02-10121.25+0.4%
2024Q3Eper share2024-10-26-0.190.0%
2024Q3Rper share2024-10-26-0.190.0%
2024Q3S-2024-10-21112.230.0%
2024Q2Eper share2024-07-16-0.170.0%
2024Q2Rper share2024-07-16-0.170.0%
2024Q2S-2024-07-16116.180.0%
2024Q1Eper share2024-05-01-0.230.0%
2024Q1Rper share2024-05-01-0.230.0%
2024Q1S-2024-05-01106.860.0%
2023FYEper share2024-02-13-0.730.0%
2023FYRper share2024-02-13-0.730.0%
2023FYS-2024-02-09396.44+0.0%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share-0.83-0.62-0.936-1.1431.09-1.016-0.657-0.952-0.240.3036-
Sales USD millions175202231207274330399465535590-
Shares million shares353940454647484950-51
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share-0.167-0.33-0.142-0.13-0.0060.0370.0020.1830.082
Sales USD millions116124124136134141141154154
Shares million shares494949505050515151

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue589.80534.53+14.9%465.31+16.5%399.25+20.8%330.38+20.4%274.33+32.8%206.53-10.5%230.81+14.5%201.63
Cost of Goods Sold Incl. D&A140.14136.79+13.2%120.80+18.6%101.83+20.6%84.44+23.3%68.47+19.7%57.22-5.4%60.47+10.9%54.51
Gross Profit449.67397.74+15.5%344.50+15.8%297.42+20.9%245.94+19.5%205.86+37.9%149.31-12.3%170.34+15.8%147.12
Selling, General and Administrative Excl. Other431.63401.19+7.7%372.52+13.4%328.51+13.8%288.61+14.0%253.16+30.7%193.76-7.0%208.37+35.8%153.42
Research and Development103.3090.17+11.1%81.16+9.8%73.92+28.9%57.34+18.2%48.51+12.6%43.07+4.5%41.23+18.8%34.72
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income18.04-3.45-28.01-31.09-42.67-47.30-44.45-38.04-6.30
Interest Expense5.785.88-8.3%6.41-7.4%6.92+38.7%4.99+1.4%4.92+0.8%4.88+18.7%4.11-10.8%4.61
Unusual Expense1.006.00-55.1%13.36-4.41-6400.0%0.07-102.50-0.24-4.92-145.5%10.82
Net Income Before Taxes16.20-10.16-43.67-29.85-46.20-191.7%50.39-48.04-34.99-20.91
Income Taxes1.311.28+25.5%1.02+72.9%0.59+118.5%0.27+42.1%0.19+72.7%0.11-45.0%0.20-13.0%0.23
Consolidated Net Income14.88-11.45-44.70-30.44-46.47-192.6%50.20-48.16-35.19-21.14
Net Income From Continuing Operations14.88-11.45-44.70-30.44-46.47-192.6%50.20-48.16-35.19-21.14
Net Income14.88-11.45-44.70-30.44-46.47-192.6%50.20-48.16-35.19-21.14
EPS (Recurring) per share0.31-0.15-0.75-0.72-1.01-0.47-1.15-1.03-0.40
EPS (Basic, Before Extraordinaries) per share0.31-0.24-0.95-0.66-1.02-191.9%1.11-1.14-0.94-0.62
EPS (Diluted) per share0.30-0.24-0.95-0.66-1.02-193.6%1.09-1.14-0.94-0.62
EBITDA39.2017.08-9.28-16.28-30.96-36.85-34.90-28.67-1270.2%2.45
Non-Operating Income (Expense)4.945.16+25.5%4.11+9.3%3.76+145.8%1.53+1430.0%0.10-90.5%1.05-53.1%2.24+173.2%0.82
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense37.3935.30+10.6%31.92+13.1%28.23+24.2%22.73+10.9%20.50+24.0%16.53+26.0%13.12+0.7%13.03
Price To Earnings Ratio ratio statement ratio, not the snapshot184.39184.39---65.38---
Price To Sales Ratio ratio4.753.533.084.146.1411.6711.355.295.17
Gross Margin %76.2474.4174.0474.4974.4475.0472.2973.8072.97
Operating Margin %3.06-0.64-6.02-7.79-12.92-17.24-21.52-16.48-3.13
Net Margin %2.52-2.14-9.61-7.62-14.0618.30-23.32-15.25-10.48
Shares Outstanding million shares50.9149.79+1.9%48.87+2.8%47.53+2.1%46.56+1.2%46.02+1.5%45.35+14.3%39.66+2.7%38.60
Market Capitalization2,850.632,850.63+91.3%1,489.90-11.9%1,691.53-18.0%2,064.04-35.4%3,193.64+27.4%2,506.44+94.9%1,285.77+9.1%1,178.93

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue154.45+15.0%153.60+12.8%141.25+14.3%140.50+13.1%134.27+15.8%136.14+17.1%123.62+13.6%124.28+16.7%
Cost of Goods Sold Incl. D&A35.83+6.3%35.71+0.8%32.67+2.9%35.92+10.8%33.70+12.8%35.42+17.4%31.75+12.1%32.42+18.0%
Gross Profit118.62+17.9%117.89+17.0%108.58+18.2%104.58+13.8%100.57+16.9%100.72+17.0%91.87+14.1%91.86+16.2%
Selling, General and Administrative Excl. Other114.26+13.9%108.23+6.2%108.05+10.5%101.09+7.1%100.36+7.4%101.91+9.3%97.82+7.0%94.38+7.6%
Research and Development31.38+41.8%25.67+9.1%23.50+7.9%22.75+2.5%22.13+9.6%23.52+19.6%21.77+9.7%22.20+6.7%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income4.35+1971.4%9.660.533.490.21-1.19-5.95-2.52
Interest Expense1.61+9.5%1.32-11.4%1.34-5.6%1.50+3.4%1.47-12.0%1.49-7.5%1.42-15.5%1.45-19.4%
Unusual Expense0.000.00-100.0%0.001.00-91.7%0.005.000.00-100.0%12.00
Net Income Before Taxes4.029.430.392.36-0.09-5.93-6.51-15.30
Income Taxes-0.05-127.8%0.47+80.8%0.29+20.8%0.60+122.2%0.18-43.8%0.26+4.0%0.24+33.3%0.27-27.0%
Consolidated Net Income4.068.960.111.76-0.27-6.19-6.75-15.57
Net Income From Continuing Operations4.068.960.111.76-0.27-6.19-6.75-15.57
Net Income4.068.960.111.76-0.27-6.19-6.75-15.57
EPS (Recurring) per share0.080.180.000.05-0.01-0.06-0.14-0.15
EPS (Basic, Before Extraordinaries) per share0.080.180.000.04-0.01-0.13-0.14-0.33
EPS (Diluted) per share0.080.180.000.04-0.01-0.13-0.14-0.33
EBITDA9.83+82.7%14.97+276.1%5.808.60+273.9%5.383.98-0.872.30
Non-Operating Income (Expense)1.28+9.4%1.08-38.3%1.21+40.7%1.37+104.5%1.17-24.0%1.75+71.6%0.86+1.2%0.67-36.2%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.86+0.5%9.73+8.4%8.91+17.1%8.90+8.5%9.81+19.8%8.98+9.4%7.61+4.0%8.20+11.4%
Price To Earnings Ratio ratio statement ratio, not the snapshot184.39-------
Price To Sales Ratio ratio4.752.402.533.553.263.133.183.10
Gross Margin %76.8076.7576.8774.4374.9073.9874.3173.91
Operating Margin %2.826.290.372.480.15-0.88-4.82-2.03
Net Margin %2.635.830.081.25-0.20-4.55-5.46-12.53
Shares Outstanding million shares50.91+2.4%50.86+2.4%50.63+2.3%49.79+1.9%49.71+2.0%49.69+2.1%49.49+2.3%48.87+2.8%
Market Capitalization2,850.63+62.7%1,416.94-12.7%1,421.08-9.9%1,966.80+32.0%1,751.97+28.3%1,622.28+47.3%1,576.86+8.9%1,489.90-11.9%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments167.43+36.4%122.72-10.6%137.28+13.4%121.11+1.7%119.09-51.2%244.22+198.6%81.80-34.2%124.40+261.1%34.45
Short Term Receivables66.65+10.5%60.34+14.9%52.50+23.0%42.69+29.3%33.02+42.6%23.15-17.5%28.05+11.3%25.20+9.2%23.08
Inventories78.49+4.2%75.33+10.9%67.90+47.8%45.93+17.9%38.96+11.2%35.03+19.1%29.41+30.8%22.48+0.1%22.45
Other Current Assets9.94+5.4%9.43+10.2%8.56+56.2%5.48+9.6%5.00+14.9%4.35+11.5%3.90+50.6%2.59+14.1%2.27
Total Current Assets322.52+20.4%267.83+0.6%266.25+23.7%215.21+9.8%196.08-36.1%306.74+114.3%143.16-18.0%174.67+112.3%82.26
Net Property, Plant & Equipment45.99-3.0%47.39+1.3%46.76+9.7%42.62+17.8%36.17+19.8%30.20-17.7%36.68+35.5%27.08-5.8%28.75
Total Investments and Advances0.000.000.00-100.0%51.51-50.6%104.34+635.8%14.18+11.8%12.680.000.00
Intangible Assets282.81-2.9%291.25-2.5%298.77+9.0%274.12-1.3%277.77-23.5%362.98-0.5%364.66+136.0%154.51-1.0%156.02
Other Assets2.86-0.3%2.87+32.9%2.16+8.5%1.99+109.5%0.95+115.9%0.44-37.1%0.70+42.9%0.49-27.9%0.68
Total Assets654.18+7.4%609.33-0.7%613.93+4.9%585.45-4.9%615.31-13.9%714.54+28.1%557.88+56.4%356.76+33.3%267.70
Short Term Debt Incl. Current Port. of LT Debt3.12+11.0%2.81+11.1%2.53+18.2%2.14+21.6%1.76+0.6%1.75-21.2%2.22-53.0%4.72+742.9%0.56
Accounts Payable25.31+1.1%25.03-8.5%27.35+37.4%19.90+7.0%18.60+46.0%12.74-14.8%14.95+54.8%9.66-22.3%12.43
Other Current Liabilities53.09+16.5%45.59+2.0%44.68+22.9%36.35+0.7%36.09+4.2%34.65+5.8%32.75+26.7%25.84+36.6%18.91
Total Current Liabilities81.52+11.0%73.42-1.5%74.57+27.7%58.39+3.4%56.45+14.9%49.14-1.6%49.92+24.1%40.22+26.1%31.90
Long Term Debt73.38-0.5%73.72+2.4%71.96+4.2%69.08-6.5%73.89+12.7%65.58-11.6%74.20+55.4%47.74+29.5%36.86
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities7.34+506.6%1.21-1.6%1.230.0%1.23+0.8%1.22-99.3%187.42+0.5%186.42+859.9%19.42-48.6%37.77
Total Liabilities162.24+9.4%148.36+0.4%147.76+14.8%128.69-2.2%131.56-56.5%302.14-2.7%310.54+189.2%107.38+0.8%106.54
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity491.94+6.7%460.97-1.1%466.17+2.1%456.75-5.6%483.76+17.3%412.39+66.7%247.34-0.8%249.38+54.7%161.17
Total Shareholders Equity491.94+6.7%460.97-1.1%466.17+2.1%456.75-5.6%483.76+17.3%412.39+66.7%247.34-0.8%249.38+54.7%161.17
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity491.94+6.7%460.97-1.1%466.17+2.1%456.75-5.6%483.76+17.3%412.39+66.7%247.34-0.8%249.38+54.7%161.17
Total Liabilities & Stockholders Equity654.18+7.4%609.33-0.7%613.93+4.9%585.45-4.9%615.31-13.9%714.54+28.1%557.88+56.4%356.76+33.3%267.70
Book Value Per Share per share9.88+4.8%9.43-3.9%9.810.0%9.81-6.7%10.51+15.6%9.09+45.7%6.24-3.4%6.46+38.6%4.66
Tangible Book Value Per Share per share4.20+21.0%3.47-1.4%3.52-10.2%3.92-12.5%4.48+311.0%1.09-2.96-220.3%2.46+1540.0%0.15
Full-Time Employees people1,350+3.8%1,300+8.3%1,200+14.3%1,050+20.0%875+16.7%750+2.7%730+17.7%620+8.8%570
Price to Book Ratio ratio5.353.203.654.586.616.125.214.743.96
Return on Assets %-1.81-7.31-5.08-7.747.55-7.57-7.70-6.77-9.88
Return on Equity %-2.40-9.64-6.60-9.8811.20-14.60-14.17-10.30-16.32
Return on Invested Capital %-2.03-8.36-5.66-8.849.00-10.07-10.95-7.11-13.58
Quick Ratio ratio2.992.622.662.902.785.532.283.781.87
Current Ratio ratio3.963.653.573.693.476.242.874.342.58

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income14.88-11.45-44.70-30.44-46.47-192.6%50.20-48.16-35.19-21.14
Depreciation21.1620.53+9.6%18.73+26.5%14.81+26.5%11.71+12.2%10.44+9.3%9.55+1.9%9.37+7.1%8.75
Other Funds (Non Cash)55.6452.54-5.3%55.46+44.8%38.29+21.6%31.50-69.57-374.5%25.34+73.2%14.63+114.8%6.81
Funds from Operations91.6961.62+109.0%29.49+30.1%22.66-3.26-8.93-13.27-11.20-5.57
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-23.14-4.29-18.36-18.24-18.88-4.85-6.64-4.62-430.0%1.40
Cash from Operating Activities68.5557.33+415.1%11.13+151.8%4.42-22.14-13.78-19.90-15.81-4.17
Capital Expenditures-15.61-9.05-11.46-42.00-16.88-9.75-5.26-12.18-6.21
Net Assets From Acquisitions-5.50-6.00-12.000.000.000.000.00-17.240.00
Sale of Fixed Assets and Businesses0.000.00-100.0%0.030.000.000.000.00-100.0%0.04+300.0%0.01
Purchase or Sale of Investments0.000.00-100.0%53.67-15.9%63.81+4.8%60.89+83.1%33.26-151.74-657.0%27.24-79.20
Purchase of Investments0.000.000.000.00-24.64-173.10-227.04-73.25-106.59
Sale Or Maturity of Investments0.000.00-100.0%53.67-15.9%63.81-25.4%85.52-58.6%206.36+174.0%75.31-25.0%100.48+266.8%27.39
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.500.000.000.000.00-100.0%0.800.000.00
Cash from Investing Activities-21.11-14.55-148.1%30.23+38.5%21.82-50.4%44.01+87.3%23.50-156.20-2.15-85.40
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-4.93-3.87-0.86-184.3%1.02-6.16-5.66-103.0%190.09-5.17-106.0%86.81
Repurchase of Common Pref Stock-12.53-11.16-6.95-6.56-12.20-18.01-13.03-9.03-4.46
Sale of Common Pref Stock7.597.29+19.7%6.09-19.7%7.58+25.5%6.04-51.1%12.36-93.9%203.12+5162.2%3.86-95.8%91.27
Proceedsfrom Stock Options0.000.000.000.000.000.00-100.0%188.960.00-100.0%82.87
Issuance or Reduction of Debt, Net-2.995.05-1.67-0.99-0.90-1.99-0.67-103.5%19.04+31.4%14.49
Change in Long Term Debt-2.995.05-1.67-0.99-0.90-1.99-0.67-103.5%19.04+31.4%14.49
Issuance of Long Term Debt0.006.25-89.8%61.210.000.00-100.0%3.830.00-100.0%19.67+21.0%16.25
Reduction of Long Term Debt-2.99-1.20-62.88-0.99-0.90-5.82-0.67-0.63-1.75
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.00-100.0%0.50-1.12
Other Financing Activities Uses0.000.000.000.000.000.000.000.00-1.12
Cash from Financing Activities-7.921.18-2.53-8533.3%0.03-7.06-7.64-104.0%189.43+1218.2%14.37-85.7%100.18
Exchange Rate Effect-0.350.75-0.42-0.06-0.36-0.37-364.3%0.14-0.16-0.18
Net Change in Cash39.1744.71+16.4%38.41+46.5%26.21+81.4%14.45+745.0%1.71-87.3%13.46-3.75-136.0%10.42
Free Cash Flow52.9448.28-0.32-7.57-39.02-23.53-25.16-27.99-10.38
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio52.9039.12-------
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments187.03+26.5%167.79+42.4%146.16+46.3%167.43+36.4%147.87+13.4%117.80+3.3%99.89-5.7%122.72-10.6%
Short Term Receivables76.13+20.9%79.98+21.2%71.31+12.6%66.65+10.5%62.98+14.7%66.00+18.8%63.32+14.5%60.34+14.9%
Inventories87.31+10.6%83.92+9.9%81.14+8.3%78.49+4.2%78.95+3.1%76.34+3.7%74.91+4.1%75.33+10.9%
Other Current Assets12.92+14.2%13.84+24.6%15.07+12.7%9.94+5.4%11.31+50.8%11.11+15.6%13.37+11.4%9.43+10.2%
Total Current Assets363.39+20.7%345.53+27.4%313.69+24.7%322.52+20.4%301.11+11.8%271.26+7.3%251.48+2.6%267.83+0.6%
Net Property, Plant & Equipment72.38+56.2%48.49+1.5%46.19-4.2%45.99-3.0%46.35-6.6%47.77+3.4%48.21+4.3%47.39+1.3%
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets275.66-3.3%278.04-3.1%280.42-3.0%282.81-2.9%284.92-2.8%287.03-2.7%289.14-2.6%291.25-2.5%
Other Assets6.11+99.7%4.58+63.6%3.69+31.8%2.86-0.3%3.06+1.7%2.80-12.5%2.80-14.4%2.87+32.9%
Total Assets717.54+12.9%676.64+11.1%643.99+8.9%654.18+7.4%635.44+3.3%608.85+1.9%591.630.0%609.33-0.7%
Short Term Debt Incl. Current Port. of LT Debt3.73+24.3%3.17+8.9%3.13+10.2%3.12+11.0%3.00+10.7%2.91+14.6%2.84+11.8%2.81+11.1%
Accounts Payable30.39+19.3%35.85+39.6%30.56+21.4%25.31+1.1%25.47-19.8%25.68-3.7%25.18-13.1%25.03-8.5%
Other Current Liabilities49.85+1.0%42.89+6.5%39.50+19.0%53.09+16.5%49.37+23.5%40.26+25.7%33.20+11.7%45.59+2.0%
Total Current Liabilities83.97+7.9%81.92+19.0%73.19+19.6%81.52+11.0%77.84+4.6%68.84+12.4%61.220.0%73.42-1.5%
Long Term Debt93.11+16.5%71.05-4.4%71.78-3.7%73.38-0.5%79.91+7.4%74.34+2.1%74.57+2.4%73.72+2.4%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities7.24+513.6%7.25+519.7%7.32+500.0%7.34+506.6%1.18-1.7%1.17-1.7%1.22-1.6%1.21-1.6%
Total Liabilities184.31+16.0%160.21+11.0%152.29+11.2%162.24+9.4%158.94+5.9%144.36+6.8%137.01+1.3%148.36+0.4%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity533.22+11.9%516.43+11.2%491.69+8.2%491.94+6.7%476.51+2.5%464.49+0.5%454.62-0.4%460.97-1.1%
Total Shareholders Equity533.22+11.9%516.43+11.2%491.69+8.2%491.94+6.7%476.51+2.5%464.49+0.5%454.62-0.4%460.97-1.1%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity533.22+11.9%516.43+11.2%491.69+8.2%491.94+6.7%476.51+2.5%464.49+0.5%454.62-0.4%460.97-1.1%
Total Liabilities & Stockholders Equity717.54+12.9%676.64+11.1%643.99+8.9%654.18+7.4%635.44+3.3%608.85+1.9%591.630.0%609.33-0.7%
Book Value Per Share per share10.47+9.2%10.15+8.6%9.71+5.7%9.88+4.8%9.59+0.5%9.35-1.5%9.19-2.5%9.43-3.9%
Tangible Book Value Per Share per share5.06+31.4%4.69+31.4%4.17+24.9%4.20+21.0%3.85+9.1%3.57+4.1%3.34+1.5%3.47-1.4%
Full-Time Employees people---1,350+3.8%---1,300+8.3%
Price to Book Ratio ratio5.352.882.894.133.773.573.423.20
Return on Assets %2.201.64-0.74-1.81-4.60-6.03-6.45-7.31
Return on Equity %2.952.15-0.97-2.40-6.11-7.85-8.38-9.64
Return on Invested Capital %0.651.520.020.31-0.05-1.15-1.27-2.91
Quick Ratio ratio3.293.193.182.992.852.832.882.62
Current Ratio ratio4.334.224.293.963.873.944.113.65

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income4.068.960.111.76-0.27-6.19-6.75-15.57
Depreciation5.47+5.8%5.31+2.7%5.27+3.7%5.11+5.8%5.17+4.9%5.17+14.1%5.08+14.2%4.83+15.6%
Other Funds (Non Cash)17.64+36.1%12.89-21.0%12.09+18.1%13.03-43.1%12.96+21.3%16.31+39.9%10.240.0%22.89+125.7%
Funds from Operations27.18+52.2%27.15+77.6%17.47+103.6%19.89+63.8%17.86+130.5%15.29+86.9%8.58+504.2%12.14+168.0%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital3.14-64.6%-4.96-178.4%-21.460.148.86-27.7%6.33+10450.0%-19.61-7.38
Cash from Operating Activities30.32+13.5%22.19+2.6%-4.0020.03+319.9%26.72+33.6%21.62+162.4%-11.034.77+18.4%
Capital Expenditures-6.39-3.77-3.85-1.60-2.60-2.66-2.18-2.69
Net Assets From Acquisitions-4.500.000.00-1.000.00-5.000.00-12.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00-100.0%0.000.00
Purchase or Sale of Investments0.000.000.000.000.00-100.0%0.00-100.0%0.00-100.0%0.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.00-100.0%0.00-100.0%0.00-100.0%0.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.00-100.0%0.000.000.000.500.00
Cash from Investing Activities-10.89-3.77-3.85-2.60-2.60-159.2%-7.66-124.8%-1.68-117.4%-14.69
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock0.33+725.0%3.60-3.0%-11.282.42+19.8%0.043.71+13.8%-10.042.02-22.9%
Repurchase of Common Pref Stock-0.54-0.31-11.44-0.23-0.36-0.41-10.17-0.19
Sale of Common Pref Stock0.88+125.6%3.91-5.1%0.16+23.1%2.65+19.9%0.39+457.1%4.12+20.5%0.13-66.7%2.21-18.1%
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.36-106.1%-0.34-1.97-0.32-140.5%5.95-0.29-0.290.79
Change in Long Term Debt-0.36-106.1%-0.34-1.97-0.32-140.5%5.95-0.29-0.290.79
Issuance of Long Term Debt0.00-100.0%0.000.000.00-100.0%6.250.000.00-100.0%1.07
Reduction of Long Term Debt-0.36-0.34-1.97-0.32-0.30-0.29-0.29-0.28
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities-0.03-100.5%3.26-4.7%-13.262.10-25.3%5.983.42+71.9%-10.322.81+19.1%
Exchange Rate Effect-0.16-0.07-113.0%-0.16-180.0%0.04-0.03-112.5%0.540.20-0.49-545.5%
Net Change in Cash19.25-36.0%21.62+20.7%-21.2619.5630.07+23.7%17.91-56.4%-22.84-7.61-305.1%
Free Cash Flow23.93-0.7%18.43-2.7%-7.8518.43+790.3%24.11+47.0%18.95+223.4%-13.212.07+66.9%
Price to Free Cash Flow ratio52.9025.7426.0939.2952.9064.57137.50-

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Appendage Management185.66220.18+18.6%41.2%
Minimally Invasive53.8439.85-26.0%7.5%
Openheart158.34184.89+16.8%34.6%
Pain Management67.4789.62+32.8%16.8%
Total465.31534.53+14.9%100.0%
Region
Name20242025vs 20242025 share
Asia Pacific27.3830.72+12.2%5.7%
Europe49.8761.49+23.3%11.5%
Other International5.246.94+32.5%1.3%
United States382.82435.37+13.7%81.4%
Total465.31534.53+14.9%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-309.99%4.9M48.9M1.02M
2026-10-1510.00%4.9M48.9M1.08M
2026-09-309.86%4.8M48.9M1.07M
2026-09-158.77%4.3M48.8M960.34K
2026-08-318.48%4.1M48.8M880.84K
2026-08-148.04%3.9M48.8M906.22K
2026-07-317.92%3.9M48.8M959.45K
2026-07-1510.02%4.9M48.6M916.06K
2026-06-309.16%4.4M48.6M873.88K
2026-06-157.09%3.4M48.6M762.05K
2026-05-297.00%3.4M48.6M745.96K
2026-05-159.13%4.4M48.6M744.59K
2026-04-307.95%3.9M48.5M732.13K
2026-04-157.45%3.6M48.5M673.70K
2026-03-317.37%3.5M48.0M666.24K
2026-03-137.11%3.4M48.0M623.78K
2026-02-276.56%3.1M48.0M622.35K
2026-02-137.18%3.4M48.0M579.05K
2026-01-305.24%2.5M47.9M521.53K
2026-01-155.24%2.5M47.9M540.32K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call30.0023.6028.5025.634.56410.000.000.874-0.6580.017
call35.0018.6023.500.003.6960.000.000.844-0.6290.020
call40.0013.8018.3013.402.8351500.000.806-0.5870.023
call45.008.6013.4011.222.24740.000.000.758-0.5310.026
call50.004.008.500.001.5920.000.000.690-0.4550.029
call55.000.204.903.401.3493.000.000.577-0.3180.032
call60.000.004.905.301.83712.000.000.466-0.3560.034
call65.000.004.901.871.5893.000.000.328-0.3030.030
call70.000.004.900.002.6390.000.000.351-0.5140.030
call75.000.004.900.212.86924.000.000.329-0.5490.030
call80.000.004.900.002.4010.000.000.218-0.3720.025
call85.000.004.900.003.5450.000.000.294-0.6400.028
put30.000.004.900.006.0690.000.00-0.126-0.6550.017
put35.000.004.900.204.9922.000.00-0.156-0.6250.020
put40.000.004.900.004.0630.000.00-0.194-0.5830.023
put45.000.004.900.003.2300.000.00-0.242-0.5260.026
put50.000.004.901.901.1701.000.00-0.200-0.1710.024
put55.000.004.903.101.6701.000.00-0.423-0.3120.032
put60.002.005.905.001.0561.000.00-0.547-0.3790.032
put65.006.5011.302.601.63020.000.00-0.591-0.4960.032
put70.0011.5016.300.001.9970.000.00-0.649-0.5060.030
put75.0016.5021.500.002.3890.000.00-0.674-0.5550.030
put80.0021.5026.4027.802.6310.000.00-0.692-0.5960.029
put85.0026.5031.500.002.9250.000.00-0.706-0.6310.028

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-05SCHEDULE 13G/ASEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-23SEC
2026-09-23144Filing for proposed sale of securities under Rule 144.SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-11144Filing for proposed sale of securities under Rule 144.SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-08144Filing for proposed sale of securities under Rule 144.SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-24144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-05144Filing for proposed sale of securities under Rule 144.SEC
2026-08-05144Filing for proposed sale of securities under Rule 144.SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-29144Filing for proposed sale of securities under Rule 144.SEC
2026-07-28144Filing for proposed sale of securities under Rule 144.SEC
2026-07-28144Filing for proposed sale of securities under Rule 144.SEC
2026-07-2710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100689.65K2
2026-100000
2026-09001.17M4
2026-0800730.85K3
2026-07001.42M3
2026-060000
2026-0500226.60K2
2026-040000
2026-0300149.15K1
2026-020000
2026-010000
2025-120000
2025-1100676.38K4

Institutional holders

Manager% owned
BlackRock, Inc.8.84%
WELLINGTON MANAGEMENT GROUP LLP6.90%
VANGUARD PORTFOLIO MANAGEMENT LLC6.18%
Hood River Capital Management LLC5.74%
ALLIANCEBERNSTEIN L.P.5.47%
VANGUARD CAPITAL MANAGEMENT LLC4.33%
STATE STREET CORP4.19%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.3.42%
GOLDMAN SACHS GROUP INC3.16%
MARSHALL WACE, LLP2.63%

Funds

Fund% owned
Hood River Small-Cap Growth Fund3.02%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.00%
Nomura Small Cap Core Fund2.71%
iShares Russell 2000 ETF2.56%
VANGUARD SMALL-CAP INDEX FUND2.18%
AB DISCOVERY GROWTH FUND, INC.1.46%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.25%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Small Cap Index Fund1.07%
Fidelity Enhanced Small Cap Core ETF0.91%

OakChart. ATRC. Cached 15 minutes. Terms